EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C30H62O10 |
| Net Charge | 0 |
| Average Mass | 582.816 |
| Monoisotopic Mass | 582.43430 |
| SMILES | CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO |
| InChI | InChI=1S/C30H62O10/c1-2-3-4-5-6-7-8-9-10-11-13-32-15-17-34-19-21-36-23-25-38-27-29-40-30-28-39-26-24-37-22-20-35-18-16-33-14-12-31/h31H,2-30H2,1H3 |
| InChIKey | ONJQDTZCDSESIW-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Role: | nonionic surfactant A surfactant with an uncharged hydrophilic headgroup. |
| Biological Roles: | sclerotherapy agent A sclerotherapy agent is used to treat blood vessels or blood vessel malformations (vascular malformations) and also those of the lymphatic system by injection into the vessels, which makes them shrink. hepatotoxic agent A role played by a chemical compound exhibiting itself through the ability to induce damage to the liver in animals. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| polidocanol (CHEBI:46859) has functional parent nonaethylene glycol (CHEBI:39784) |
| polidocanol (CHEBI:46859) has role hepatotoxic agent (CHEBI:50908) |
| polidocanol (CHEBI:46859) has role nonionic surfactant (CHEBI:38828) |
| polidocanol (CHEBI:46859) has role sclerotherapy agent (CHEBI:63923) |
| polidocanol (CHEBI:46859) is a hydroxypolyether (CHEBI:46792) |
| IUPAC Name |
|---|
| 3,6,9,12,15,18,21,24,27-nonaoxanonatriacontan-1-ol |
| Synonyms | Source |
|---|---|
| DODECYL NONA ETHYLENE GLYCOL ETHER | PDBeChem |
| Nonaethylene glycol monododecyl ether | KEGG COMPOUND |
| nonaethylene glycol monolauryl ether | ChEBI |
| Polidocanol | KEGG COMPOUND |
| Manual Xrefs | Databases |
|---|---|
| C13493 | KEGG COMPOUND |
| CE9 | PDBeChem |
| Polidocanol | Wikipedia |
| Registry Numbers | Sources |
|---|---|
| Reaxys:1895308 | Reaxys |
| CAS:3055-99-0 | ChemIDplus |
| CAS:3055-99-0 | KEGG COMPOUND |
| Citations |
|---|